PULMONARY EMBOLISM Dr. Abdul-Monim Batiha, RN, MSN, PhD 1.
-
Upload
julius-hall -
Category
Documents
-
view
217 -
download
1
Transcript of PULMONARY EMBOLISM Dr. Abdul-Monim Batiha, RN, MSN, PhD 1.
PULMONARY EMBOLISM
Dr. Abdul-Monim Batiha, RN, Dr. Abdul-Monim Batiha, RN, MSN, PhDMSN, PhD
11
Pulmonary embolism (PE)
• Pulmonary embolism (PE) refers to the obstruction of the pulmonary artery or one of its branches by a thrombus (or thrombi) that originates somewhere in the venous system or in the right side of the heart.
• Most commonly, PE is due to a blood clot or thrombus.
22
•However, there are other types of emboli: air, fat, amniotic fluid, and septic (from bacterial invasion of the thrombus).
• It is estimated that more than half a million people develop PE yearly, resulting in more than 50,000 deaths.
33
•PE is a common disorder and often is associated with trauma, surgery (orthopedic, major abdominal, pelvic, gynecologic), pregnancy, heart failure, age older than 50 years, hypercoagulable states, and prolonged immobility. It also may occur in an apparently healthy person
44
Risk Factors for Thromboembolism
Hereditary Thrombophilias■ Protein C deficiency■ Protein S deficiency■ Antithrombin III deficiency■ Factor V Leiden mutation■ Prothrombin 20210 G–A variation■ HyperhomocysteinemiaAcquired Surgical Predisposition■ Major thoracic or abdominal
surgery requiring general anesthesia and lasting >30 minutes
■ Hip arthroplasty■ Knee arthroplasty■ Knee arthroscopy■ Hip fracture■ Major trauma■ Open prostatectomy■ Spinal cord injury■ Neurosurgical procedures
Acquired Medical Predisposition
■ Prior venous thromboembolism
■ Age >40 years■ Malignant neoplasia■ Congestive heart failure■ Cerebrovascular accident■ Nephrotic syndrome■ Estrogen therapy■ Pregnancy and the
postpartum period■ Obesity■ Prolonged immobilization■ Antiphospholipid antibody
syndrome■ Lupus anticoagulant■ Inflammatory bowel disease
55
Pathophysiology
• When a thrombus completely or partially obstructs a pulmonary artery or its branches, the alveolar dead space is increased.
• The area, although continuing to be ventilated, receives little or no blood flow.
• Thus, gas exchange is impaired or absent in this area.
• In addition, various substances are released from the clot and surrounding area, causing regional blood vessels and bronchioles to constrict.
66
77
88
Pathophysiology
•This causes an increase in pulmonary vascular resistance.
•This reaction compounds the ventilation–perfusion imbalance.
99
Pathophysiology•The hemodynamic consequences are
increased pulmonary vascular resistance from the regional vasoconstriction and reduced size of the pulmonary vascular bed.
• In patients with no preexisting cardiopulmonary disease, obstruction of less than 20% of the pulmonary vascular bed produces compensatory events that minimize adverse hemodynamic consequences.
1010
Pathophysiology•When the degree of pulmonary vascular
obstruction exceeds 30% to 40%, increases in pulmonary artery pressure occur, followed by modest increases in right atrial pressure.
• When the work requirements of the right ventricle exceed its capacity (the degree of pulmonary artery obstruction exceeds 50% to 60% )right ventricular failure occurs, leading to a decrease in cardiac output followed by a decrease in systemic blood pressure and the development of shock.
1111
Signs and Symptoms of Pulmonary Embolism
Small to Moderate Embolus
■ Dyspnea■ Tachypnea■ Tachycardia■ Chest pain■ Mild fever■ Hypoxemia■ Apprehension■ Cough■ Diaphoresis■ Decreased breath sounds
over affected area■ Rales■ Wheezing
Massive EmbolusA more pronounced
manifestation of the above signs and symptoms, plus the following:
■ Cyanosis■ Restlessness■ Anxiety■ Confusion■ Hypotension■ Cool, clammy skin■ Decreased urinary output■ Pleuritic chest pain:
associated with pulmonary infarction
■ Hemoptysis: associated with pulmonary infarction
1212
Signs of Pulmonary Embolism in Intensive Care Patients
■ Worsening hypoxemia in a patient on spontaneous ventilation
■ Worsening hypoxemia and hypercapnia in a sedate patient on controlled mechanical ventilation
■ Worsening dyspnea, hypoxemia, and a reduction inPaCO2 in a patient with chronic lung disease and
knowncarbon dioxide retention■ Unexplained fever■ Sudden elevation in pulmonary artery pressure or
centralvenous pressure in a hemodynamically monitoredpatient
1313
Diagnostic EvaluationDiagnostic Evaluation
• ABG levels: decreased PaoABG levels: decreased Pao22 is usually is usually found, due to perfusion abnormality found, due to perfusion abnormality of the lung.of the lung.
• Chest X-ray: normal or possible Chest X-ray: normal or possible wedge-shaped infiltrate.wedge-shaped infiltrate.
1414
• lung scans: perfusion scan lung scans: perfusion scan investigates regional blood flow to investigates regional blood flow to determine presence of perfusion determine presence of perfusion defects; ventilation scan may be defects; ventilation scan may be done in patient with large perfusion done in patient with large perfusion defects.defects.
• Pulmonary angiogram (most Pulmonary angiogram (most definitive): emboli seen as filling definitive): emboli seen as filling defects.defects.
1515
Management
•Heparin and thrombolytic agents are used to treat PE.
•Patients with DVT or pulmonary embolism should be treated with unfractionated intravenous heparin or adjusted-dose subcutaneous heparin.
• (For subcutaneous treatment with unfractionated heparin, give 250 U/kg every 12 hours to obtain an activated partial thromboplastin time [aPTT] with therapeutic range at 6 to 8 hours.)
1616
Management
•Low–molecular-weight heparin (LMWH) can be substituted for unfractionated heparin in patients with DVT and in stable patients with pulmonary embolism.
• Treatment with heparin or LMWH should continue for at least 5 days, overlapped with oral anticoagulation for at least 4 to 5 days
1717
• The recommended length of anticoagulation therapy varies, depending on the patient’s age, comorbidities, and the likelihood of recurrence of pulmonary embolism or DVT.
• In most patients, anticoagulation therapy with warfarin should be continued for 3 to 6 months
1818
• Thrombolytic therapy is only recommended for patients with acute massive pulmonary mbolism who are hemodynamically unstable and not prone to bleeding.
• Intracranial disease, recent surgery, trauma, and hemorrhagic disease are contraindications to thrombolytic therapy
1919
•Placement of an inferior vena cava filter is recommended to prevent pulmonary embolism in patients with contraindications to heparin therapy.
•And also recommended in patients with recurring thromboembolism despite adequate anticoagulation, chronic recurrent embolism and pulmonary hypertension, and concurrent surgical pulmonary embolectomy or pulmonary endarterectomy procedures
2020
FIGURE 11-2 Insertion of umbrella filter in inferior vena cava to prevent pulmonary embolism. Filter (compressed within an applicator catheter) is inserted through an incision in the right internal jugular vein. The applicator is withdrawn when the filter fixes itself to the wall of the inferior vena cava after ejection from the applicator. 2121
Prevention
•Prevention of venous thromboembolism is essential to decreasing the morbidity and mortality associated with pulmonary embolism.
•Prophylactic measures are based on the patient’s specific risk factors.
2222
Nursing DiagnosesNursing Diagnoses
• Ineffective Breathing Pattern related Ineffective Breathing Pattern related to acute increase in alveolar dead to acute increase in alveolar dead airspace and possible changes in airspace and possible changes in lung mechanics from embolismlung mechanics from embolism
• Ineffective Tissue Perfusion Ineffective Tissue Perfusion (Pulmonary) related to decreased (Pulmonary) related to decreased blood circulationblood circulation
2323
• Acute Pain (pleuritic) related to Acute Pain (pleuritic) related to congestion, possible pleural effusion, congestion, possible pleural effusion, possible lung infarctionpossible lung infarction
• Anxiety related to dyspnea, pain, and Anxiety related to dyspnea, pain, and seriousness of conditionseriousness of condition
• Risk for Injury related to altered Risk for Injury related to altered hemodynamic factors and hemodynamic factors and anticoagulant therapyanticoagulant therapy
2424
Nursing InterventionsNursing Interventions
2525
Correcting Breathing Correcting Breathing PatternPattern
• Assess for hypoxia, headache, Assess for hypoxia, headache, restlessness, apprehension, pallor, restlessness, apprehension, pallor, cyanosis, behavioral changes.cyanosis, behavioral changes.
• Monitor vital signs, ECG, oximetry, Monitor vital signs, ECG, oximetry, and ABG levels for adequacy of and ABG levels for adequacy of oxygenation.oxygenation.
• Monitor patient's response to I.V. Monitor patient's response to I.V. fluids/vasopressors.fluids/vasopressors.
2626
• Monitor oxygen therapy used to Monitor oxygen therapy used to relieve hypoxemia.relieve hypoxemia.
• Prepare patient for assisted Prepare patient for assisted ventilation when hypoxemia is due to ventilation when hypoxemia is due to local areas of pneumoconstriction local areas of pneumoconstriction and abnormalities of V/Q ratios.and abnormalities of V/Q ratios.
2727
Improving Tissue Improving Tissue PerfusionPerfusion
• Closely monitor for shock, decreasing Closely monitor for shock, decreasing blood pressure, tachycardia, cool, blood pressure, tachycardia, cool, clammy skin.clammy skin.
• Monitor prescribed medications given Monitor prescribed medications given to preserve right ventricular filling to preserve right ventricular filling pressure and increase blood pressure and increase blood pressure.pressure.
2828
• Maintain patient on bed rest to Maintain patient on bed rest to reduce oxygen demands and risk of reduce oxygen demands and risk of bleeding.bleeding.
• Monitor urinary output hourly, Monitor urinary output hourly, because there may be reduced renal because there may be reduced renal perfusion and decreased glomerular perfusion and decreased glomerular filtration.filtration.
2929
Relieving PainRelieving Pain
• Watch patient for signs of discomfort Watch patient for signs of discomfort and pain.and pain.
• Ascertain if pain worsens with deep Ascertain if pain worsens with deep breathing and coughing; auscultate breathing and coughing; auscultate for friction rub.for friction rub.
• Give prescribed morphine Give prescribed morphine (Duramorph), and monitor for pain (Duramorph), and monitor for pain relief and signs of respiratory relief and signs of respiratory depression.depression.
3030
• Position with head of bed slightly Position with head of bed slightly elevated (unless contraindicated by elevated (unless contraindicated by shock) and with chest splinted for shock) and with chest splinted for deep breathing and coughing.deep breathing and coughing.
3131
• Evaluate patient for signs of hypoxia Evaluate patient for signs of hypoxia thoroughly when anxiety, restlessness, thoroughly when anxiety, restlessness, and agitation of new onset are noted, and agitation of new onset are noted, before administering as needed before administering as needed sedatives. Consider physician sedatives. Consider physician evaluation when these signs are evaluation when these signs are present, especially if accompanied by present, especially if accompanied by cyanotic nail beds, circumoral pallor, cyanotic nail beds, circumoral pallor, and increased respiratory rate.and increased respiratory rate.
3232
Reducing AnxietyReducing Anxiety
• Correct dyspnea and relieve physical Correct dyspnea and relieve physical discomfort.discomfort.
• Explain diagnostic procedures and Explain diagnostic procedures and the patient's role; correct the patient's role; correct misconceptions.misconceptions.
• Listen to the patient's concerns; Listen to the patient's concerns; attentive listening relieves anxiety attentive listening relieves anxiety and reduces emotional distress.and reduces emotional distress.
3333
• Speak calmly and slowly.Speak calmly and slowly.
• Do everything possible to enhance Do everything possible to enhance the patient's sense of control.the patient's sense of control.
3434
Evaluation: Expected Evaluation: Expected OutcomesOutcomes
• Verbalizes less shortness of breathVerbalizes less shortness of breath
• Vital signs stable, adequate urinary Vital signs stable, adequate urinary outputoutput
• Reports freedom from painReports freedom from pain
• Appears more relaxed; sleeping at Appears more relaxed; sleeping at long intervalslong intervals
• Progresses without complicationsProgresses without complications
3535
Good Good LuckLuck
3636